Mirtazapine Generics [uk] (Mirtazapine)

Mirtazapine works by blocking central alpha‑2 adrenergic receptors, which increases the release of norepinephrine and serotonin. It also selectively antagonises 5‑HT2 and 5‑HT3 receptors, further enhancing serotonergic neurotransmission and contributing to its antidepressant and anxiolytic effects.

The appropriate dose of mirtazapine is determined by the prescribing clinician based on the individual’s clinical condition, response to therapy, and tolerability. Dosage may be started low and adjusted gradually; patients should follow the specific instructions provided by their healthcare professional.

Safety data for mirtazapine in pregnancy and lactation are limited. Healthcare providers should weigh the potential benefits against possible risks before prescribing to pregnant or nursing women. The decision should be made on a case‑by‑case basis in consultation with a qualified medical professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After verification of trade or institutional credentials, the sales team will respond with pricing, availability, shipping details and any required import documentation.

Compared with SSRIs or SNRIs, mirtazapine has a distinct mechanism that often results in stronger sedative and appetite‑stimulating effects. This can be advantageous for patients with insomnia or weight loss, but may be less suitable for those who wish to avoid weight gain. Efficacy in depression is comparable, while side‑effect profiles differ.

Mirtazapine Generics should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

Mirtazapine is taken orally, usually once daily in the evening due to its sedative properties. Tablets should be swallowed whole with water and not chewed or crushed unless otherwise directed by a healthcare professional.

Serious risks include agranulocytosis, severe skin reactions such as Stevens‑Johnson syndrome, hepatic dysfunction, seizures, and the potential for worsening depression or emergence of suicidal thoughts, especially during early treatment or dose changes.

Mirtazapine is contraindicated in patients with known hypersensitivity to the drug, those currently taking monoamine oxidase inhibitors, or individuals with severe hepatic impairment. Caution is also advised for patients with a history of bipolar disorder, uncontrolled hypertension, or significant cardiac disease.